A New Prognostic Instrument for Predicting the Probability of Completion of Cisplatin during Chemoradiation for Head and Neck Cancer

Many head and neck cancer patients assigned to definitive or adjuvant chemoradiation treatment do not complete the concurrent cisplatin dose. We determined corresponding risk factors and developed a prognostic instrument to help identify these patients. Ten pre-treatment characteristics were retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rades, Dirk, Zwaan, Inga, Idel, Christian, Pries, Ralph, Bruchhage, Karl L., Hakim, Samer G., Yu, Nathan Y., Soror, Tamer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381843/
https://www.ncbi.nlm.nih.gov/pubmed/37511733
http://dx.doi.org/10.3390/jpm13071120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10381843/
https://www.ncbi.nlm.nih.gov/pubmed/37511733
http://dx.doi.org/10.3390/jpm13071120

Ejemplares similares